On this page we presented the PCRX Historical PE Ratio information for Pacira BioSciences' stock. The average PCRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 52.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PCRX historical PE based on this TTM earnings result method is 41.7. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PCRX historical PE result, against the recent PE: when this page was posted on 11/7/2024, the most recent closing price for PCRX had been 17.70, and the most recent quarterly earnings result, annualized, was 3.16. Meanwhile, the most recent TTM earnings summed to 3.19. From these numbers, we calculate the recent PCRX PE on 11/7/2024 based on annualized quarterly EPS was 5.6. Based on PCRX's history, that recent PE is low relative to the historical average, with the recent PE 89.4% lower than the historical average PE across our data set for Pacira BioSciences. Looking at the recent PCRX PE on 11/7/2024 based on TTM EPS, we calculate the ratio at 5.5. Based on PCRX's history, that recent PE is low relative to the historical average, with the recent PE 86.8% lower than the average PE across our Pacira BioSciences data set with TTM EPS used in the calculation at each period.

Another interesting PCRX historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for PCRX, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for PCRX, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.62, 0.79, 0.89, and 0.89. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.79 and 0.89 — which gives us the median of 0.84. Basically the way to think about this 0.84 number is this: for the trailing four earnings reports, 0.84 marks the "middle ground" number where PCRX has reported a value higher than 0.84 half the time, and has reported a value lower than 0.84 half the time. Annualizing that median value then gets us to 3.36/share, which we use as the denominator in our next PE calculation. With 17.70 as the numerator (as of 11/7/2024), the calculation is then 17.70 / 3.36 = 5.3 as the PCRX PE ratio as of 11/7/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on PCRX or any other given stock, valuation analysis for PCRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Pacira BioSciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PCRX. Thanks for visiting, and the next time you need to research PCRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.